| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a9f8eff85227fd96744c754de382d6b2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2227-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2800-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8509
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-0275
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-0276 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-027 |
| filingDate |
2017-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd92e68fb88e234235525dfcbbc0577d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_835584870369404cc70621d19545f737
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa4a5e02e623ce1d96ad16781c61c653
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8335223244d685467fbc8b4a61e18a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_330c1ad919b06ea455bc32d0a17e773f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24e889d3b98efa69fecebbec6099c827 |
| publicationDate |
2017-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2017121256-A |
| titleOfInvention |
Antibody-producing non-human mammal |
| abstract |
The present invention provides a transgenic non-human animal comprising a nucleic acid encoding an immunoglobulin light chain, wherein the immunoglobulin light chain is human, human-like or humanized. The nucleic acid comprises means for conferring resistance to DNA rearrangement and / or somatic hypermutation. In one embodiment, the nucleic acid comprises an expression cassette for expression of a desired molecule in a cell that is in a particular stage of development in a cell that develops in a mature B cell. The present invention further provides a method of producing an immunoglobulin from the transgenic non-human animal. [Selection figure] None |
| priorityDate |
2008-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |